Inbios International INC
At a glance
Employees20-99
In business sinceNot reported
HeadquartersSeattle, WA
SAM.gov UEICNJNQ1GMSN55
InBios International designs and manufactures immunodiagnostics for infectious diseases including Chagas, dengue, scrub typhus, strongyloidiasis, West Nile virus, and other emerging infectious diseases and biothreats. The company offers contract manufacturing and assay development services. Its products serve diagnostic laboratories, including veterinary diagnostic laboratories.
Summarized from the company’s own website
What they make
Coronavirus Antigen Detection Test System.Dengue Serological ReagentsDengue Virus Antigen AssayElisa, Antibody, West Nile VirusElisa, Trichinella SpiralisEnzyme Linked Immunosorbent Assay, T. CruziLeishmania Spp. Antigen Detection AssayOver-The-Counter Covid-19 Antigen TestReagent, Coronavirus SerologicalReagent, Leishmanii SerologicalReagent, Rickettsia SerologicalReagents, 2019-Novel Coronavirus Nucleic AcidReagents, Specific, AnalyteSimple In Vitro Diagnostic Device For The Detection Of Secreted Proteins From Bacillus Spp. In Human Clinical SamplesSimple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient SettingsZika Virus Serological Reagents
Certifications
FDA registeredISO 13485
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Inbios International INC | Seattle | WA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.